On August 24, 2023, TMS hosted an incredibly informative and powerful webinar describing the findings of the PIONEER trial of Avapritinib in patients with indolent systemic mastocytosis (ISM).

Over the course of the hour long webinar, we heard findings from the trial from Dr. Mariana Castells, we heard from a patient who had direct experience with Avapritinib, and we answered YOUR questions in a panel conversation. You can watch below, or find the webinar in our library here:

We will be creating a follow-up document that answers the questions we got from registrants of the webinar. Stay tuned for more on that.

In the meantime, here are some resources from the webinar:

We have updated our Patient Assistance page to share resources that help patients with financial challenges, due to their medical conditions. We know that prescription medications can be extremely expensive and so the page includes copay assistance programs for various medications that mast cell patients might need, including Ayvakit®. You can see the list of programs here:

Click on the picture to download a PDF of Dr. Castells’ presentation.

Click on the picture to download a PDF of the TMS presentation, including before and after patient pictures, as well as resources.

Skip to content